WGS, WES, and Targeted Gene Panels for Your Disease Research

As a company with innovative sequencing and genotyping technologies, CD Genomics uses the NGS Panel platform to provide a series of proprietary, ultra-high multiplexed target enrichment technology that integrates the company’s advanced panel design. The disease panels are designed to address the practical needs of various disease studies. https://www.cd-genomics.com/diseasepanel/ready-to-use-ngs-panel.html